CD8A and neoplasm: Moreover, TECs select specific subsets of immune cells to infiltrate the tumor tissue, favoring Treg and macrophage precursors (MDSC), but inhibiting CD4+ and CD8+ effector T cells, DCs, natural killer (NK) cells and neutrophil granulocytes (De Sanctis et al., 2018).